1Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis[J]. Lance,2003, 362(9388): 971-982.
2Grundtman C, Tham E, Ulfgren AK, et al. Vascular endothelial gruwth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis[J]. Arthritis Rheum, 2008, 58(10): 3224- 3238.
3Walsh R J, Kong SW, Yao Y, et al. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis [J]. Arthritis Rheum, 2007, 56(11):3784-3792.
4Bilgic H, Ytterberg SR, Amin S, et al. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis [J]. Arthritis Rheum, 2009, 60(11):3436-3446.
5Nagaraju K, Casciola-Rosen L, Lundberg I, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction[J]. Arthritis Rheum, 2005, 52(6):1824- 1835.
6Grundtman C, Bruton J, Yamada T, et al. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies[J]. FASEB J, 2010 24(2):570- 578.
7Stone KB, Oddis CV, Fertig N, et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy[J]. Arthritis Rheum, 2007, 56(9): 3125-3131.
8Katsumata Y, Ridgway WM, Oriss T, et al. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation[J]. J Autoimmun, 2007, 29(2-3):174- 186.
9Mammen AL, Casciola-Rosen LA, Hall JC, et al. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle[J]. Arthritis Rheum, 2009, 60(12):3784- 3793.
10Mammen AL. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis[J]. Ann N Y Acad Sci, 2010,1184:134-153.
2Lemos EM,Santoro PP,Tavares RA,et al.Oropharyngeal dysphagia in dermatomyosites:case report and literature review.Braz J Otorhinolaryngol,2008,74(6):938-940.
3Bohan A, Peter JB. Polymyositis and dermatomyositis( first of two parts) [ J ]. N Engl J Med, 1975,292 (7) :344 - 347.
4Chiu SK, Yang YH, Wang LC, et al. Ten - year experience of juvenile dermatomyositis:A retrospective study [ J ]. J Microbiol lmmunol Infect, 2007,40( 1 ) :68 -73.
5Grundtman C, Malmstrom V, Lundberg IE. Immune mechanismsin the pathogenesis of idiopathic inflammatory myopathies [ J ]. Arthritis Res T- her,2007,9(2) : 208.
6Verma S, Singh S, Bhalla AK,et al. Study of subcutaneous fat in chil- dren with juvenile dermatomyositis[ J]. Arthritis Rheum,2006,55 ( 4 ) : 564 - 568.
8Olsen N, Park J. Inflammatory myopathies: issues in diagnosis and management. Arthritis Care Res, 1997,10 : 200.
9Hoogendijk J, Amato A, Lecky B, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10 - 12 October 2003, Naarden, The Netherlands. Neuromuscul Disord, 2004, 14: 337.
10Cantwell C, Ryan M, Obonnell M, et al. A comparison of inflammato- ry myopathies at whole-body turbo STIR MRI. Clinical Radiology, 2005,60:261.
